DSM updates financial markets at its Capital Markets Day

Royal DSM, the global Life Sciences and Materials Sciences company, today will provide investors with an update on its strategic progress and current priorities at its annual Capital Markets Day, which will be held in London, United Kingdom.

Feike Sijbesma, CEO and Chairman of the DSM Managing Board, said: "DSM has made strong strategic progress, significantly transforming the company in recent years. In light of current market conditions, our focus is on improving the operational performance of our Nutrition and Performance Materials businesses, while continuing to pursue strategic actions for Polymer Intermediates and Composite Resins. We remain committed to long-term shareholder value generation."

At the Capital Markets Day, DSM will provide an update on its strategic progress and operational performance and in that context will address:

Improving performance of the Nutrition and Performance Materials businessesInitiatives focused on operational efficiencies and cash generationOngoing portfolio enhancement with strategic actions pursued for Polymer Intermediates (Caprolactam and Acrylonitrile) and Composite ResinsExpanding global presenceValue generation in the Pharma partnershipsUnlocking the value of innovation investmentsStrict capital allocation

Webcast and presentations
The DSM Capital Markets Day can be followed live via audio webcast from 15.00-18.00 hrs (CET). The presentations can be found on www.dsm.com as from 15.00 hrs (CET).

DSM - Bright Science. Brighter Living.(TM)

Royal DSM is a global science-based company active in health, nutrition and materials. By connecting its unique competences in Life Sciences and Materials Sciences DSM is driving economic prosperity, environmental progress and social advances to create sustainable value for all stakeholders simultaneously. DSM delivers innovative solutions that nourish, protect and improve performance in global markets such as food and dietary supplements, personal care, feed, medical devices, automotive, paints, electrical and electronics, life protection, alternative energy and bio-based materials. DSM's 24,500 employees deliver annual net sales of around €10 billion. The company is listed on NYSE Euronext. More information can be found at www.dsm.com.

Or find us on:        

For more information:

DSM Corporate Communications Herman Betten
tel.+31(0)455782017 
e-mail media.contacts@dsm.comDSM Investor Relations Dave Huizing
tel. +31(0)45 5782864
email investor.relations@dsm.comPress release-pdf


This announcement is distributed by Nasdaq OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: DSM N.V. via Globenewswire
HUG#1868657